Skip to main content

Advertisement

Log in

Lucio’s phenomenon: report of five cases

  • Case Based Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The different clinical forms of leprosy are mainly related to the variety of immunological responses to the infection. Several forms of lepromatous leprosy are recognized, including macular, nodular, and diffuse. Lucio’s phenomenon is a rare but distinctive skin eruption seen in patients with diffuse lepromatous leprosy. The diffuse lesions of Lucio’s phenomenon have a predilection for the extremities, can include nodules, and heal with atrophic stellate scars; histologically, a necrotizing vasculitis accompanied by a nonspecific inflammatory reaction may be seen. Because of its rarity and similarity with some manifestations of the rheumatic disease and other causes of vasculitis, Lucio’s phenomenon may not be easily recognized, especially in non-endemic countries, which leads to confusing diagnosis and loss of time for treatment. We report five patients with vasculitis caused by Lucio’s phenomenon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Organización Mundial de la Salud. Estadísticas sanitarias mundiales 2011, pag 18

  2. World Health Organization. Leprosy updates 2011. Weekly Epidemiological Record September 2011, vol. 86, n 36 (pp 389–400)

  3. Cuevas J, Rodríguez-Peralto JL, Carrillo R, Contreras F (2007) Erythema nodosum leprosum: reactional leprosy. Semin Cutan Med Surg 26:126–130

    Article  CAS  PubMed  Google Scholar 

  4. Pernambuco JC, Cossermelli-Messina W (1993) Rheumatic manifestations of leprosy: clinical aspects. J Rheumatol 20:897–899

    CAS  PubMed  Google Scholar 

  5. Roverano S, Paira S, Somma F (2000) Lucio’s phenomenon: report of two cases and review of the literature. J Clin Rheumatol 6:210–213

    Article  CAS  PubMed  Google Scholar 

  6. Paira S, Roverano S (1991) The rheumatic manifestation of leprosy. Clin Rheumatol 10:274–276

    Article  CAS  PubMed  Google Scholar 

  7. Magaña M, Fernández-Díez J, Magaña ML (2008) Lucio’s phenomenon is a necrotizing panvasculitis: mostly a medium-sized granulomatous arteritis. Am J Dermatopathol 30:555–560

    Article  PubMed  Google Scholar 

  8. Vargas OF (2007) Diffuse leprosy of Lucio and Latapí: a histologic study. Lepr Rev 78:248–260

    Google Scholar 

  9. Rea TH, Levan NE (1978) Lucio’s phenomenon and diffuse nonnodular lepromatous leprosy. Arch Dermatol 114:1023–1028

    Article  CAS  PubMed  Google Scholar 

  10. Pursley TV, Jacobson RR (1980) Lucio’s phenomenon. Arch Dermatol 116:201–204

    Article  CAS  PubMed  Google Scholar 

  11. Kaur C, Thami GP, Mohan H (2005) Lucio phenomenon and Lucio leprosy. Clin Exp Dermatol 30:525–527

    Article  CAS  PubMed  Google Scholar 

  12. Quismorio FP Jr, Rea T, Chandor S, Levan N, Friou GJ (1978) Lucio’s phenomenon: an immune complex deposition syndrome in lepromatous leprosy. Clin Immunol Immunopathol 9:184–193

    Article  PubMed  Google Scholar 

  13. Moschella SL (1967) The lepra reaction with necrotizing skin lesions: a report of six cases. Arch Dermatol 95:565–575

    Article  CAS  PubMed  Google Scholar 

  14. Donner R, Shively J (1967) The Lucio’s phenomenon in diffuse leprosy. Ann Intern Med 67:831–836

    Article  CAS  PubMed  Google Scholar 

  15. Chavez-Legaspi M, Gomez-Vazquez A, García-De La Torre I (1985) Study of rheumatic manifestations and serologic abnormalities in patients with lepromatous leprosy. J Rheumatol 12:738–741

    CAS  PubMed  Google Scholar 

  16. Pradhan V, Badakere SS, Shankar KU (2004) Increased incidence of cytoplasmic ANCA (cANCA) and other auto antibodies in leprosy patients from western India. Lepr Rev 75:50–56

    PubMed  Google Scholar 

  17. Zavala-Cerna MG, Fafutis-Morris M, Guillen-Vargas C et al (2012) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico. Rheumatol Int 32:3531–3536

    Article  CAS  PubMed  Google Scholar 

  18. de Larrañaga GF, Forastiero RR, Martinuzzo ME et al (2000) High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 9:594–600

    Article  PubMed  Google Scholar 

  19. Loizou S, Singh S, Wypkema E, Asherson RA (2003) Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 62:1106–1111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Gelber R (1995) (Hansen’s disease) In: Mandell G, Bennett J, Dolin R, editors. Principles and Practice of Infectous Diseases. 4th ed. Vol 2. New York: Churchill-Livingston; P 2243–50

Download references

Acknowledgments

The authors are grateful to Raúl Galoppe, Ph.D. (Montclair State University) for his help in translating the manuscript.

Disclosure

The authors declare that they have none to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergio Paira.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Curi, P.F., Villaroel, J.S., Migliore, N. et al. Lucio’s phenomenon: report of five cases. Clin Rheumatol 35, 1397–1401 (2016). https://doi.org/10.1007/s10067-014-2683-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2683-2

Keywords

Navigation